Related Experiment Videos
Bioactive acridone alkaloids from Swinglea glutinosa
B Weniger1, B H Um, A Valentin
1UMR 7081, Faculté de Pharmacie, Université Louis Pasteur Strasbourg, BP 24, 67401 Illkirch Cedex, France. weninger@pharma.u-strasbg.fr
Journal of Natural Products
|September 29, 2001
Summary
A novel prenylated acridone alkaloid was isolated from Swinglea glutinosa. This compound and others were tested for antimalarial activity against Plasmodium falciparum and cytotoxicity.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Swinglea glutinosa is a plant source of bioactive compounds.
- Acridone alkaloids exhibit diverse biological activities, including antimalarial properties.
- Drug resistance in Plasmodium falciparum necessitates the search for new antimalarial agents.
Purpose of the Study:
- To isolate and characterize new and known acridone alkaloids from Swinglea glutinosa.
- To evaluate the in vitro antimalarial activity of these alkaloids against chloroquine-sensitive and -resistant Plasmodium falciparum strains.
- To assess the cytotoxicity of the isolated alkaloids using HeLa cells.
Main Methods:
- Phytochemical investigation of Swinglea glutinosa stembark.
- Isolation and structure elucidation of alkaloids using spectroscopic methods.
- In vitro antimalarial assays against Plasmodium falciparum.
- Cytotoxicity assays using HeLa cell line.
Main Results:
- A new prenylated acridone alkaloid, 1,3,5-trihydroxy-2,8-bis(3-methylbut-2-enyl)-10-methyl-9-acridone, was identified.
- Three known acridone alkaloids (5-hydroxynoracronycine, and two methoxy-substituted derivatives) were also isolated.
- The antimalarial activity and cytotoxicity profiles of these compounds were determined.
Conclusions:
- Swinglea glutinosa is a valuable source of acridone alkaloids with potential antimalarial properties.
- Further investigation into these alkaloids may lead to the development of new antimalarial drugs.
- The cytotoxicity data provides essential information for assessing the therapeutic potential of these compounds.